Sitagliptin--another option for managing type 2 diabetes in dialysis patients?
- PMID: 23497767
- DOI: 10.1053/j.ajkd.2013.01.004
Sitagliptin--another option for managing type 2 diabetes in dialysis patients?
Comment in
-
In reply to 'Primary objective of study of sitagliptin in patients with ESRD on dialysis'.Am J Kidney Dis. 2013 Sep;62(3):642-3. doi: 10.1053/j.ajkd.2013.06.009. Am J Kidney Dis. 2013. PMID: 23972059 No abstract available.
-
Primary objective of study of sitagliptin in patients with ESRD on dialysis.Am J Kidney Dis. 2013 Sep;62(3):642. doi: 10.1053/j.ajkd.2013.05.026. Am J Kidney Dis. 2013. PMID: 23972060 No abstract available.
Comment on
-
Efficacy and safety of sitagliptin in patients with type 2 diabetes and ESRD receiving dialysis: a 54-week randomized trial.Am J Kidney Dis. 2013 Apr;61(4):579-87. doi: 10.1053/j.ajkd.2012.11.043. Epub 2013 Jan 24. Am J Kidney Dis. 2013. PMID: 23352379 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical